{"transactions":[{"id":903280,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:11:16.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":7390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":7390,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":7390},"source":{"system":"sec-edgar","filing":"0000875045-26-000030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000030/form4.xml","form_type":"4"}},{"id":913163,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":6087,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":3043},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913162,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1802,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913161,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2044},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913160,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":775,"price":201.18,"value":155914.5,"ownership":{"direct":true},"balance_after":11011,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913159,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11786,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913158,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":201.18,"value":92140.44,"ownership":{"direct":true},"balance_after":8743,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913157,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9201,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913156,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":805,"price":201.18,"value":161949.9,"ownership":{"direct":true},"balance_after":7399,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913155,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order."}],"balance_after":8204,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":1087007,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-07-16T21:55:39.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":2223,"price":135,"value":300105.0,"ownership":{"direct":true},"balance_after":6330,"source":{"system":"sec-edgar","filing":"0001127602-25-019295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225019295/form4.xml","form_type":"4"}},{"id":1272562,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:40:05.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":1515},"source":{"system":"sec-edgar","filing":"0001127602-25-004452","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004452/form4.xml","form_type":"4"}},{"id":1272561,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T22:40:05.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":445,"price":142.54,"value":63430.3,"ownership":{"direct":true},"balance_after":8553,"source":{"system":"sec-edgar","filing":"0001127602-25-004452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004452/form4.xml","form_type":"4"}},{"id":1272560,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T22:40:05.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order."}],"balance_after":8998,"source":{"system":"sec-edgar","filing":"0001127602-25-004452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004452/form4.xml","form_type":"4"}},{"id":1275037,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":3604,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1801},"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1275036,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":2044,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2043},"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1275035,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7860,"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1275034,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":565,"price":141.35,"value":79862.75,"ownership":{"direct":true},"balance_after":6059,"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1275033,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":600,"price":141.35,"value":84810.0,"ownership":{"direct":true},"balance_after":6624,"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1275032,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2025-02-12T02:52:04.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order."}],"balance_after":7224,"source":{"system":"sec-edgar","filing":"0001127602-25-004243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004243/form4.xml","form_type":"4"}},{"id":1277545,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:49:58.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":9130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":9130,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":9130},"source":{"system":"sec-edgar","filing":"0001127602-25-003959","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003959/form4.xml","form_type":"4"}},{"id":1630993,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630992,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":807,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":647},"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630991,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":1370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1370},"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630990,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":313,"price":219.08,"value":68572.04,"ownership":{"direct":true},"balance_after":9701,"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630989,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":647,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10014,"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630988,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":639,"price":219.08,"value":139992.12,"ownership":{"direct":true},"balance_after":9367,"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1630987,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-22T02:33:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":1370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10006,"source":{"system":"sec-edgar","filing":"0001127602-24-006216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006216/form4.xml","form_type":"4"}},{"id":1647457,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T23:00:42.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":1515,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":1515},"source":{"system":"sec-edgar","filing":"0001127602-24-004794","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004794/form4.xml","form_type":"4"}},{"id":1647456,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-13T23:00:42.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":445,"price":240.98,"value":107236.1,"ownership":{"direct":true},"balance_after":8636,"source":{"system":"sec-edgar","filing":"0001127602-24-004794","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004794/form4.xml","form_type":"4"}},{"id":1647455,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-13T23:00:42.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9081,"source":{"system":"sec-edgar","filing":"0001127602-24-004794","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004794/form4.xml","form_type":"4"}},{"id":1652225,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:11:05.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":4087,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2043},"source":{"system":"sec-edgar","filing":"0001127602-24-004308","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004308/form4.xml","form_type":"4"}},{"id":1652224,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:11:05.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":5405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":5405,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":5405},"source":{"system":"sec-edgar","filing":"0001127602-24-004308","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004308/form4.xml","form_type":"4"}},{"id":1652223,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-10T01:11:05.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":621,"price":240.3,"value":149226.3,"ownership":{"direct":true},"balance_after":7566,"source":{"system":"sec-edgar","filing":"0001127602-24-004308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004308/form4.xml","form_type":"4"}},{"id":1652222,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2024-02-10T01:11:05.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8187,"source":{"system":"sec-edgar","filing":"0001127602-24-004308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004308/form4.xml","form_type":"4"}},{"id":1665788,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:31:59.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":1370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":1370,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1370},"source":{"system":"sec-edgar","filing":"0001127602-24-002807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002807/form4.xml","form_type":"4"}},{"id":1838169,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-07-05T21:37:23.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on July 1, 2020, and vested in three equal installments on each anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":504},"source":{"system":"sec-edgar","filing":"0001127602-23-020238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020238/form4.xml","form_type":"4"}},{"id":1838168,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-07-05T21:37:23.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":244,"price":284.85,"value":69503.4,"ownership":{"direct":true},"balance_after":6144,"source":{"system":"sec-edgar","filing":"0001127602-23-020238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020238/form4.xml","form_type":"4"}},{"id":1838167,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-07-05T21:37:23.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6388,"source":{"system":"sec-edgar","filing":"0001127602-23-020238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223020238/form4.xml","form_type":"4"}},{"id":2001569,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:57:18.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This number represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1454,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":681},"source":{"system":"sec-edgar","filing":"0001127602-23-006513","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006513/form4.xml","form_type":"4"}},{"id":2001568,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:57:18.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2135,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":767},"source":{"system":"sec-edgar","filing":"0001127602-23-006513","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006513/form4.xml","form_type":"4"}},{"id":2001567,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-22T21:57:18.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":371,"price":278.38,"value":103278.98,"ownership":{"direct":true},"balance_after":5117,"source":{"system":"sec-edgar","filing":"0001127602-23-006513","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006513/form4.xml","form_type":"4"}},{"id":2001566,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-22T21:57:18.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":767,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5884,"source":{"system":"sec-edgar","filing":"0001127602-23-006513","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006513/form4.xml","form_type":"4"}},{"id":2017916,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"other","acquired":false,"shares":553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":553},"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017915,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":553,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":453},"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017914,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":3030,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":1515},"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017913,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":642,"price":286.3,"value":183804.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 27, 2023."}],"balance_after":5488,"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017912,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":220,"price":286.3,"value":62986.0,"ownership":{"direct":true},"balance_after":6130,"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017911,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":453,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6350,"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017910,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":462,"price":286.3,"value":132270.6,"ownership":{"direct":true},"balance_after":5897,"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2017909,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2023-02-15T02:41:44.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":1515,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6359,"source":{"system":"sec-edgar","filing":"0001127602-23-005271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005271/form4.xml","form_type":"4"}},{"id":2023666,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:47:17.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":6130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":6130,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":6130},"source":{"system":"sec-edgar","filing":"0001127602-23-004578","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004578/form4.xml","form_type":"4"}},{"id":2044272,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2023-01-27T22:55:14.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":1783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023."}],"balance_after":4844,"source":{"system":"sec-edgar","filing":"0001127602-23-002481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002481/form4.xml","form_type":"4"}},{"id":2095010,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"other","acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This award was granted to the reporting person on December 2, 2019.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award was granted to the reporting person on December 2, 2019.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":433},"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095009,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award was granted to the reporting person on December 2, 2019.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":433,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":425},"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095008,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":1285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on December 2, 2019, and vested in full on December 2, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":1285},"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095007,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":189,"price":298.9,"value":56492.1,"ownership":{"direct":true},"balance_after":3061,"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095006,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":425,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3250,"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095005,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":570,"price":298.9,"value":170373.0,"ownership":{"direct":true},"balance_after":2825,"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2095004,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-12-06T23:37:53.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":1285,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3395,"source":{"system":"sec-edgar","filing":"0001127602-22-026993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026993/form4.xml","form_type":"4"}},{"id":2213200,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-07-06T23:28:26.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on July 1, 2020, and will vest in three equal installments on each anniversary of the grant date."}],"balance_after":504,"derivative":{"exercise_price":0,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":504},"source":{"system":"sec-edgar","filing":"0001127602-22-019020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019020/form4.xml","form_type":"4"}},{"id":2213199,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-07-06T23:28:26.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":148,"price":210.63,"value":31173.24,"ownership":{"direct":true},"balance_after":2110,"source":{"system":"sec-edgar","filing":"0001127602-22-019020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019020/form4.xml","form_type":"4"}},{"id":2213198,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-07-06T23:28:26.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2258,"source":{"system":"sec-edgar","filing":"0001127602-22-019020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222019020/form4.xml","form_type":"4"}},{"id":2380149,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:16:59.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2902,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":854},"source":{"system":"sec-edgar","filing":"0001127602-22-006269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006269/form4.xml","form_type":"4"}},{"id":2380148,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:16:59.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3756,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":594},"source":{"system":"sec-edgar","filing":"0001127602-22-006269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006269/form4.xml","form_type":"4"}},{"id":2380147,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-02-23T21:16:59.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":175,"price":209.79,"value":36713.25,"ownership":{"direct":true},"balance_after":1754,"source":{"system":"sec-edgar","filing":"0001127602-22-006269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006269/form4.xml","form_type":"4"}},{"id":2380146,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-02-23T21:16:59.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":594,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1929,"source":{"system":"sec-edgar","filing":"0001127602-22-006269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006269/form4.xml","form_type":"4"}},{"id":2395627,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:14:45.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1006,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":651},"source":{"system":"sec-edgar","filing":"0001127602-22-004988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004988/form4.xml","form_type":"4"}},{"id":2395626,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:14:45.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1657,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":351},"source":{"system":"sec-edgar","filing":"0001127602-22-004988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004988/form4.xml","form_type":"4"}},{"id":2395625,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-02-15T21:14:45.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":122,"price":214.59,"value":26179.98,"ownership":{"direct":true},"balance_after":1335,"source":{"system":"sec-edgar","filing":"0001127602-22-004988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004988/form4.xml","form_type":"4"}},{"id":2395624,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2022-02-15T21:14:45.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":351,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1457,"source":{"system":"sec-edgar","filing":"0001127602-22-004988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004988/form4.xml","form_type":"4"}},{"id":2399478,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:18:49.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":4545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":4545,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":4545},"source":{"system":"sec-edgar","filing":"0001127602-22-004781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004781/form4.xml","form_type":"4"}},{"id":2484362,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2021-12-06T21:14:53.000Z","date":"2021-12-02","kind":"other","acquired":false,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This number represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on December 2, 2019.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":858,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":484},"source":{"system":"sec-edgar","filing":"0001127602-21-030351","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030351/form4.xml","form_type":"4"}},{"id":2484361,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Restricted Stock Unit","published_at":"2021-12-06T21:14:53.000Z","date":"2021-12-02","kind":"exercise","acquired":false,"shares":372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on December 2, 2019.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1342,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":372},"source":{"system":"sec-edgar","filing":"0001127602-21-030351","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030351/form4.xml","form_type":"4"}},{"id":2484360,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2021-12-06T21:14:53.000Z","date":"2021-12-02","kind":"tax_withholding","acquired":false,"shares":165,"price":228.52,"value":37705.8,"ownership":{"direct":true},"balance_after":1106,"source":{"system":"sec-edgar","filing":"0001127602-21-030351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030351/form4.xml","form_type":"4"}},{"id":2484359,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Alzheimer's Disease"}}],"security":"Common Stock","published_at":"2021-12-06T21:14:53.000Z","date":"2021-12-02","kind":"exercise","acquired":true,"shares":372,"price":228.52,"value":85009.44,"ownership":{"direct":true},"balance_after":1271,"source":{"system":"sec-edgar","filing":"0001127602-21-030351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221030351/form4.xml","form_type":"4"}}]}